Found: 28
Select item for more details and to access through your institution.
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
- Published in:
- JAMA Internal Medicine, 2021, v. 181, n. 2, p. 195, doi. 10.1001/jamainternmed.2020.6319
- By:
- Publication type:
- Article
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 2, p. 332, doi. 10.1111/bjh.13771
- By:
- Publication type:
- Article
'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 369, doi. 10.1111/bjh.12901
- By:
- Publication type:
- Article
Could treatment with R- HCVAD/ R- MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma?
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 1, p. 145, doi. 10.1111/bjh.12702
- By:
- Publication type:
- Article
Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.
- Published in:
- Diagnostic Pathology, 2016, v. 11, p. 1, doi. 10.1186/s13000-016-0588-x
- By:
- Publication type:
- Article
Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 869, doi. 10.1007/s00262-020-02708-3
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 6, p. 818, doi. 10.1007/s11307-021-01627-8
- By:
- Publication type:
- Article
Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas.
- Published in:
- Cancers, 2024, v. 16, n. 19, p. 3430, doi. 10.3390/cancers16193430
- By:
- Publication type:
- Article
The role of FDG- PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 1, p. 7, doi. 10.1002/cam4.322
- By:
- Publication type:
- Article
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e730, doi. 10.1016/j.clml.2022.04.012
- By:
- Publication type:
- Article
Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/7625926
- By:
- Publication type:
- Article
Management of relapsed cutaneous T‐Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 7, p. 1, doi. 10.1111/dth.15538
- By:
- Publication type:
- Article
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01542-9
- By:
- Publication type:
- Article
The importance of multidisciplinary healthcare for paraneoplastic pemphigus.
- Published in:
- Special Care in Dentistry, 2015, v. 35, n. 3, p. 143, doi. 10.1111/scd.12093
- By:
- Publication type:
- Article
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 879, doi. 10.1002/ajh.24792
- By:
- Publication type:
- Article
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 672, doi. 10.1002/ajh.24372
- By:
- Publication type:
- Article
Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 10, p. 890, doi. 10.1002/ajh.23524
- By:
- Publication type:
- Article
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 8, p. 657, doi. 10.1002/ajh.23468
- By:
- Publication type:
- Article
Inhibition of cell-mediated immunity by the histone deacetylase inhibitor vorinostat: Implications for therapy of cutaneous T-cell lymphoma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 2, p. 226, doi. 10.1002/ajh.22231
- By:
- Publication type:
- Article
Determinants of the optimal first-line therapy for follicular lymphoma: A decision analysis.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 4, p. 255, doi. 10.1002/ajh.21655
- By:
- Publication type:
- Article
Post-transplant outcomes of induction therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 12, p. 1071, doi. 10.1002/ajh.21038
- By:
- Publication type:
- Article
A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 2, p. 222, doi. 10.1002/cncr.28405
- By:
- Publication type:
- Article
Outcomes and Toxicities of Programmed Death‐1 (PD‐1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real‐World, Multicenter Retrospective Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 955, doi. 10.1634/theoncologist.2018-0538
- By:
- Publication type:
- Article
Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder.
- Published in:
- Clinical Transplantation, 2005, v. 19, n. 5, p. 644, doi. 10.1111/j.1399-0012.2005.00388.x
- By:
- Publication type:
- Article
Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. 15, doi. 10.1093/infdis/jiae106
- By:
- Publication type:
- Article